These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12598441)

  • 1. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.
    Kashiwagi K; Tsukahara S
    Br J Ophthalmol; 2003 Mar; 87(3):297-301. PubMed ID: 12598441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension.
    Chiba T; Kashiwagi K; Chiba N; Tsukahara S
    Br J Ophthalmol; 2006 Mar; 90(3):314-7. PubMed ID: 16488953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Travoprost and Nonsteroidal Anti-Inflammatory Drug on Diurnal Intraocular Pressure in Normal Subjects with Low-Teen Baseline Intraocular Pressure.
    Sakata R; Sakisaka T; Matsuo H; Miyata K; Aihara M
    J Ocul Pharmacol Ther; 2016; 32(6):365-70. PubMed ID: 27294589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of different dose schedules of latanoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
    Gelatt KN; MacKay EO
    Vet Ophthalmol; 2001 Dec; 4(4):283-8. PubMed ID: 11906665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two- and three-times-daily topical ophthalmic application of 0.005% latanoprost solution in clinically normal dogs.
    Tofflemire KL; Whitley EM; Allbaugh RA; Ben-Shlomo G; Robinson CC; Overton TL; Thiessen CE; Evans EA; Griggs AN; Adelman SA; Ludwig AL; Jens JK; Ellinwood NM; Peterson CS; Whitley RD
    Am J Vet Res; 2015 Jul; 76(7):625-31. PubMed ID: 26111092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of clinical effects of bromfenac sodium ophthalmic solution 0.1% versus glucocorticoids for post-LASEK usage].
    Chen S; Jiang Y; Yu C; Li Y
    Zhonghua Yan Ke Za Zhi; 2015 Jan; 51(1):45-50. PubMed ID: 25877710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of topical ophthalmic latanoprost 0.005% solution alone and in combination with diclofenac 0.1% solution in healthy horses: a pilot study.
    Tofflemire K; Whitley EM; Allbaugh R; Ben-Shlomo G; Griggs A; Strong T; Whitley RD
    Vet Ophthalmol; 2017 Sep; 20(5):398-404. PubMed ID: 27791324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the effects of 0.1% bromfenac sodium eye drops and corticosteroids after small incision lenticule extraction].
    Jiang Y; Li Y; Jin YM; Zhang JY
    Zhonghua Yan Ke Za Zhi; 2017 Jan; 53(1):18-22. PubMed ID: 28162195
    [No Abstract]   [Full Text] [Related]  

  • 10. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
    Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
    Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical efficacy of 0.1% bromfenac sodium hydrate ophthalmic solution after excimer laser in situ keratomileusis].
    Xu Y; Zhao X; Zhang FJ; Wang MM; Guo N; Zheng Y; Liu J; Zhang QL
    Zhonghua Yan Ke Za Zhi; 2013 Apr; 49(4):320-6. PubMed ID: 23900091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of topical ophthalmic latanoprost on intraocular pressure in normal horses.
    Davidson HJ; Pinard CL; Keil SM; Brightman AH; Sargeant JM
    Vet Ther; 2002; 3(1):72-80. PubMed ID: 12050830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost.
    Costagliola C; Campa C; Perri P; Parmeggiani F; Romano MR; Incorvaia C
    Curr Eye Res; 2008 May; 33(5):477-82. PubMed ID: 18568885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time Course of Prostaglandin Analog-related Conjunctival Hyperemia and the Effect of a Nonsteroidal Anti-inflammatory Ophthalmic Solution.
    Sakata R; Sakisaka T; Matsuo H; Miyata K; Aihara M
    J Glaucoma; 2016 Mar; 25(3):e204-8. PubMed ID: 25642812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of topically applied flurbiprofen or bromfenac ophthalmic solution on post-operative ocular hypertension in canine patients following cataract surgery.
    Lu J; English R; Nadelstein B; Weigt A; Berdoulay A; Binder D; Ngan E
    Vet Ophthalmol; 2017 Mar; 20(2):107-113. PubMed ID: 26990912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Randomized parallel group study of 0.0015% tafluprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension (comparison with 0.005% latanoprost ophthalmic solution)].
    Ge J; Li X; Sun X; He X; Zhang H
    Zhonghua Yan Ke Za Zhi; 2015 Feb; 51(2):95-102. PubMed ID: 25907999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
    Ota T; Murata H; Sugimoto E; Aihara M; Araie M
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of latanoprost when stored at room temperature.
    Mochizuki H; Itakura H; Takamatsu M; Kiuchi Y
    Hiroshima J Med Sci; 2008 Jun; 57(2):69-72. PubMed ID: 18717189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crossover comparison of timolol and latanoprost in chronic primary angle-closure glaucoma.
    Sihota R; Saxena R; Agarwal HC; Gulati V
    Arch Ophthalmol; 2004 Feb; 122(2):185-9. PubMed ID: 14769594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect on intraocular pressure of latanoprost once or four times daily.
    Lindén C; Alm A
    Br J Ophthalmol; 2001 Oct; 85(10):1163-6. PubMed ID: 11567957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.